1. Home
  2. VACI vs CADL Comparison

VACI vs CADL Comparison

Compare VACI & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VACI

Viking Acquisition Corp. I Class A Ordinary Shares

N/A

Current Price

$9.96

Market Cap

310.8M

ML Signal

N/A

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

N/A

Current Price

$5.10

Market Cap

280.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VACI
CADL
Founded
2025
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
310.8M
280.3M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
VACI
CADL
Price
$9.96
$5.10
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$18.50
AVG Volume (30 Days)
75.1K
1.2M
Earning Date
01-01-0001
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$125,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.86
$4.25
52 Week High
$10.07
$9.08

Technical Indicators

Market Signals
Indicator
VACI
CADL
Relative Strength Index (RSI) 52.24 44.27
Support Level $9.94 $4.55
Resistance Level $9.97 $6.16
Average True Range (ATR) 0.02 0.24
MACD -0.00 0.01
Stochastic Oscillator 60.00 50.00

Price Performance

Historical Comparison
VACI
CADL

About VACI Viking Acquisition Corp. I Class A Ordinary Shares

Viking Acquisition Corp I is a blank check company.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: